Anti Walker 256 carcinoma agent and combination thereof

Details Anti Walker 256 carcinoma agent and combination thereof Anti Walker 256 carcinoma agent and combination thereof

1980-08-20

1982-05-04

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant or stably-transformed bacterium encoding one or...

424166, A61K 31235, A61K 3302

Patent

active

043282466

ABSTRACT:
Clofibrate which lowers blood triglycerides has been found to be an affective anti Walker 256 carcinoma agent and when combined with hydrazine sulfate therapy the inhibition of growth of malignant Walker 256 carcinoma is outstanding.

REFERENCES:
Chemical Abstracts 74: 110208j, (1971).
Weitzen et al, Z. Physiol. Chem. 348, pp. 433-442.

Affiliated with

Also associated with

Rating

Anti Walker 256 carcinoma agent and combination thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti Walker 256 carcinoma agent and combination thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti Walker 256 carcinoma agent and combination thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-881763